Infinity Pharmaceuticals

Listing Websites about Infinity Pharmaceuticals

Filter Type:

Infinity Pharmaceuticals

(5 days ago) Infinity Reports Clinical and Translational Data from Expansion Cohorts of MARIO‑1 Phase 1b Study of IPI-549 in Combination with Opdivo® (nivolumab) at SITC's 33rd Annual Meeting Read the Details. Role of PI3K-gamma. Role of PI3K-gamma. Learn More. Infinity Pharmaceuticals, Inc. 784 Memorial Drive Cambridge, MA 02139 617-453-1000

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Infinity Pharmaceuticals, Inc. (INFI) Stock Price, News, …

(6 days ago) Infinity Pharmaceuticals (INFI) Reports Q1 Loss, Tops Revenue Estimates Infinity (INFI) delivered earnings and revenue surprises of 0% and 65.06%, respectively, for …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Piper Sandler Trims Infinity Pharmaceuticals (NASDAQ:INFI) Target …

(1 days ago) 12 hours ago · Shares of INFI stock opened at $0.63 on Monday. Infinity Pharmaceuticals has a 1-year low of $0.46 and a 1-year high of $3.89. The company has a market capitalization of $55.86 million, a price-to

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Why Infinity Pharmaceuticals Is Skyrocketing Today - Fool

(3 days ago) Shares of biotech company Infinity Pharmaceuticals ( INFI -3.85% ) are soaring through the roof on Thursday following the company's release of data from a …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


The Stars are Aligning for Holders of Infinity Pharmaceuticals Inc

(1 days ago) Infinity Pharmaceuticals Inc. (INFI) is priced at $0.54 after the most recent trading session. At the very opening of the session, the stock price was $0.7351 and reached a high price of $0.748, prior to closing the session it reached the value of $0.68. The stock touched a low price of $0.6665.Recently in News on May 3, 2022, Infinity

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Infinity Pharmaceuticals Stock Forecast, Price & News

(6 days ago) Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of …

Url: Visit Now

Category:  Pharmaceutical,  Cancer Detail Drugs


Infinity Pharmaceuticals - Crunchbase Company Profile & Funding

(4 days ago) Founders Eric Lander, Frank Moss, Michael Foely. Operating Status Active. Last Funding Type Post-IPO Equity. Legal Name Infinity Pharmaceuticals, Inc. Stock Symbol NASDAQ:INFI. Company Type For Profit. Contact Email [email protected] Phone Number 617-453-1000. Infinity is a clinical-stage biotechnology company developing eganelisib, a potentially

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Zacks: Analysts Expect Infinity Pharmaceuticals, Inc. (NASDAQ:INFI

(9 days ago) Infinity Pharmaceuticals posted sales of $510,000.00 during the same quarter last […] Wall Street brokerages expect Infinity Pharmaceuticals, Inc. (NASDAQ:INFI – Get Rating) to post $520,000

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Infinity Pharmaceuticals Reviews Glassdoor

(7 days ago) 22 Infinity Pharmaceuticals reviews. A free inside look at company reviews and salaries posted anonymously by employees.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


INFI Infinity Pharmaceuticals Inc. — Stock Price and Discussion

(4 days ago) Infinity Pharmaceuticals Inc. NASDAQ Updated May 18, 2022 11:46 PM INFI 0.62 0.06 (8.62%). Post-Market 0.02 (2.92%)

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Infinity Pharmaceuticals Outlines Eganelisib Clinical Development

(5 days ago) Infinity Pharmaceuticals, Inc. (“Infinity” or the “Company”), is a clinical-stage biotechnology company developing eganelisib (IPI-549), a first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which is designed to address a fundamental biologic mechanism of immune suppression in cancer in multiple clinical studies

Url: Visit Now

Category:  Pharmaceutical,  Cancer Detail Drugs


Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) Short Interest Update

(6 days ago) Infinity Pharmaceuticals, Inc. (NASDAQ:INFI – Get Rating. Shares of NASDAQ INFI opened at $0.62 on Thursday. The firm has a market cap of $55.22 million, a P/E ratio of -1.19 and a beta of 2.16.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Infinity Pharmaceuticals Inc. (INFI) distance from 20-day Simple …

(9 days ago) Infinity Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.4100 on 01/03/22, with the lowest value was $0.4605 for the same time period, recorded on 05/12/22.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Zacks: Brokerages Expect Infinity Pharmaceuticals, Inc.

(4 days ago) Wall Street brokerages forecast that Infinity Pharmaceuticals, Inc. (NASDAQ:INFI – Get Rating) will report $520,000.00 in sales for the current fiscal quarter, according to Zacks Investment Research. Three analysts have issued estimates for Infinity Pharmaceuticals’ earnings, with the lowest sales estimate coming in at $200,000.00 and the

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Infinity Pharmaceuticals (INFI) Stock Price, News & Info The …

(9 days ago) Infinity Pharmaceuticals stock is today's top gainer after forging a collaborative licensing deal for its lead experimental drug, IPI-145. Why InterMune, Zulily, and Infinity Pharmaceuticals Are

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Why Infinity Pharmaceuticals Shot Nearly 4% Higher Today

(2 days ago) Infinity Pharmaceuticals ( INFI 4.63%) got off to a market-beating start this week as its shares zoomed 3.8% higher Monday, on the back of new analyst coverage that made an extremely bullish case

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Infinity Pharmaceuticals Company Profile - Office Locations

(1 days ago) Infinity Pharmaceuticals has 25 employees at their 1 location and $1.72 M in annual revenue in FY 2020. See insights on Infinity Pharmaceuticals including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Infinity Pharmaceuticals Reports First Quarter 2022 Financial Results

(2 days ago) Infinity Pharmaceuticals, Inc. (“Infinity” or the “Company”), is a clinical-stage biotechnology company developing eganelisib (IPI-549), a first-in …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Infinity Pharmaceuticals, Inc. (INFI) Latest Stock News & Headlines

(2 days ago) Infinity Pharmaceuticals (INFI) Reports Q4 Loss, Tops Revenue Estimates Infinity (INFI) delivered earnings and revenue surprises of 7.14% and 10.54%, respectively, for the quarter ended December 2021.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Infinity Pharmaceuticals News Today Why did Infinity …

(1 days ago) Infinity Pharmaceuticals (NASDAQ:INFI) Downgraded to "Sell" at StockNews.com americanbankingnews.com - May 7 at 1:08 AM: Infinity Pharmaceuticals GAAP EPS of -$0.14 in-line, revenue of $0.65M beats by $0.39M seekingalpha.com - May 4 at 12:16 AM: Infinity Pharmaceuticals, Inc. (INFI) CEO Adelene Perkins on Q1 2022 Results - …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Opportunities - Infinity Pharmaceuticals, Inc - Infinity

(1 days ago) Agency Policy: Any recruiter or agency seeking to work with Infinity Pharmaceuticals (the Company) must initially contact our Human Resources Group and enter into an approved search agreement. A search agreement must be in place prior to submitting a resume for consideration. Regardless of past practice, any resumes submitted by recruiters or search firms to any …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


INFINITY PHARMACEUTICALS, INC. : INFI Stock Price

(4 days ago) Infinity Pharmaceuticals, Inc. clinical-stage biopharmaceutical company that is focused on developing medicines for people with cancer. The Company is focused on advancing eganelisib, also known as IPI-549, an orally administered, clinical-stage, immuno-oncology product candidate that reprograms macrophages through selective inhibition of the enzyme …

Url: Visit Now

Category:  Pharmaceutical,  Cancer Detail Drugs


Infinity Pharmaceuticals Reports First Quarter 2022 Financial Results

(2 days ago) Infinity Pharmaceuticals, Inc. ("Infinity" or the "Company"), is a clinical-stage biotechnology company developing eganelisib (IPI-549), a first-in …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) Expected to Post …

(6 days ago) Infinity Pharmaceuticals, Inc operates as a biopharmaceutical company, which engages in discovering, developing and delivering medicines for people with cancer. It focuses on drug development. The

Url: Visit Now

Category:  Pharmaceutical,  Cancer Detail Drugs


Infinity Pharmaceuticals (NasdaqGS:INFI) - Simply Wall St

(2 days ago) Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of

Url: Visit Now

Category:  Pharmaceutical,  Cancer Detail Drugs


Infinity Pharmaceuticals, Inc. (INFI) CEO Adelene Perkins on Q1 …

(7 days ago) Infinity Pharmaceuticals, Inc. (NASDAQ:NASDAQ:INFI) Q1 2022 Earnings Conference Call May 03, 2022, 04:30 AM ET Company Participants Jayne Kauffman - Senior Executive Coordinator Adelene

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Infinity Pharmaceuticals to Participate in Upcoming H.C.

(3 days ago) Infinity Pharmaceuticals, Inc. ("Infinity" or the "Company"), is a clinical-stage biotechnology company developing eganelisib (IPI-549), a first-in …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Infinity Resources - Home

(4 days ago) 1200 US Route 22 East, Suite 2000, Bridgewater, NJ 08807-2943 ; 732-502-9518; [email protected]infinity-resources.com

Url: Visit Now

Category:  Health Detail Drugs


The following are changes in constituents for the MSCI US …

(5 days ago) infinity pharmaceuticals pacific bioscience of ca select income reit orchard supply epam systems novatel wireless proto labs eagle bulk shipping annies metabolix us silica holdings overseas shipholding grp

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Morning Movers (INFI, RVBD, SOA, INFA, F) - 24/7 Wall St

(9 days ago) These include Infinity Pharmaceuticals Inc. (NASDAQ: INFI), Riverbed Technology Inc. (NASDAQ: RVBD), Solutia Inc. (NYSE: SOA), Informatica Corp. (NASDAQ: INFA), and Ford Motor Co. (NYSE: F). After

Url: Visit Now

Category:  Pharmaceutical Detail Drugs

Popular Searched

 › Myuhcmedicare com hwp products catalog 2022

 › Mars hill family medicine

 › Va health insurance cost

 › Hospital nursery nurse job description

 › Focused care allenbrook baytown

 › Health partners formulary pa

 › Health partners medicare formulary

 › Geha formulary drug list 2020

 › Family care partners portal

 › Highmark formulary drug list 2020

Recently Searched

 › Ft jackson pharmacy hours

 › Preferred cherokee pharmacy dalton

 › Jobs for health information tech

 › Bidmc medical record request

 › Trinity health my workday jobs

 › Pennsylvania drug abuse statistics

 › Drug dealer simulator mouse problems

 › Family medicine review book

 › La jolla village medical

 › Schedule iv drugs list

FAQ about Infinity Pharmaceuticals

What does Infinity Pharmaceuticals do?

Infinity Pharmaceuticals, Inc. ("Infinity" or the "Company"), is a clinical-stage biotechnology company developing eganelisib (IPI-549), a first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic in multiple clinical studies.

Should you buy Infinity Pharmaceuticals (Infi) stock based on recent options moves?

Investors need to pay close attention to Infinity Pharmaceuticals (INFI) stock based on the movements in the options market lately. If there was a competition for the stock market’s most volatile stock, it’s likely the recent gyrations of Infinity Pharmaceuticals (INFI) will make it one of the front runners.

When is Infinity Pharmaceuticals' next quarterly earnings announcement?

Infinity Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Monday, November 8th 2021. View our earnings forecast for Infinity Pharmaceuticals. How were Infinity Pharmaceuticals' earnings last quarter? Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) released its quarterly earnings results on Tuesday, July, 27th.

Is Infinity Pharmaceuticals the stock market’s most volatile stock?

If there was a competition for the stock market’s most volatile stock, it’s likely the recent gyrations of Infinity Pharmaceuticals (INFI) will make it one of the front runners. The past week has seen huge swings in both directions, making it hard to know where the stock is heading next.